Wharton's Jelly – Regenative Labs

Application of Umbilical Cord Tissue Allografts in Reduction Mammoplasty Wound: A Case Study

Dec 12, 2022

Click Here to Read the Case Study Abstract Nearly 15 million patients undergo cosmetic surgery in the United States each… Read More >

Human Umbilical Cord Tissue Allografts Observational Data Collection Study of Knee with Osteoarthritis

Evaluation of the Efficacy of Cryopreserved Human Umbilical Cord Tissue Allografts to Augment Functional and Pain Outcome Measures in Patients with Knee Osteoarthritis: An Observational Data Collection Study

Sep 05, 2022

Click Here to Read the Complete Case Study Abstract The primary objective of this study is to report the initial… Read More >

Regenative Labs’ Study Opens The Door For Advanced Treatment Of Degenerating Tissue In Knee Joints

Aug 22, 2022

PENSACOLA, Fla., Aug. 22, 2022 PENSACOLA, Fla., Aug. 22, 2022 /PRNewswire/ — Regenative Labs, a leading HCT/P manufacturer, has co-authored… Read More >

Regenative Labs announces groundbreaking Wharton’s Jelly research demonstrating HCT/P compliance after processing

Aug 15, 2022

This includes the analogous nature of articular cartilage, muscle fascia, and intervertebral disc confirmed by way of comparative Scanning Electron… Read More >

Regenative Labs Receives First National Medicare/Medicaid Insurance Reimbursement Approval for Wharton’s Jelly Allografts

Regenative Labs: Medicare Approval for Wharton’s Jelly Reimbursement

Aug 05, 2020

PENSACOLA, FLA. (PRWEB) AUGUST 05, 2020 Regenative Labs has received approval from the Centers for Medicare & Medicaid Services (CMS)… Read More >